Cash & equivalents decreased 49.2%
Cash & equivalents changed -49.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -49.2% from the comparable as-filed period.
Gross margin changed -218 basis points from the comparable as-filed period.
Operating income changed +15.3% from the comparable as-filed period.
Revenue changed +14.1% from the comparable as-filed period.
Stock-based compensation changed +35.2% from the comparable as-filed period.
Research & development changed +21.7% from the comparable as-filed period.
SBC / revenue changed +213 basis points from the comparable as-filed period.
Operating margin changed +14 basis points from the comparable as-filed period.
Gross profit changed +10.8% from the comparable as-filed period.
Net income changed -4.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.